As of 1:30 PM on the 1st, Humasis is trading at 8,310 KRW, down 12.25% from the previous day. This represents a 46.04% decline compared to June 24. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 474,719 shares, while foreigners and institutions have net sold 97,968 shares and 237,029 shares, respectively.
On June 25, Humasis became a market issue with the headline "Plunges to the lower limit price after 6 consecutive gains."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
